Aggravation of albuminuria by metabolic syndrome in type 2 diabetic Asian subjects

Diabetes Research and Clinical Practice

Volumn 81, Issue 3, 2008, Pages 345-350

  Lee, I Te ^a,b   Huang, Chien Ning ^b   Lee, Wen Jane ^a,c   Lee, Hong Shen ^b   Sheu, Wayne H H ^a,b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

C reactive protein; Diabetes; Metabolic syndrome; Urinary albumin excretion

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN;

ADULT; ALBUMIN BLOOD LEVEL; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL;

AGED; ALBUMINURIA; ASIAN CONTINENTAL ANCESTRY GROUP; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; TAIWAN;

EID: 48949105818     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.05.010     Document Type: Article

References (38)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA 285 (2001) 2486-2497.
2. Sattar N., Gaw A., Scherbakova O., Ford I., O'Reilly D.S., Haffner S.M., et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108 (2003) 414-419
3. Aizawa Y., Kamimura N., Watanabe H., Aizawa Y., Makiyama Y., Usuda Y., et al. Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence. Int. J. Cardiol. 109 (2006) 213-218
4. Chien K.L., Hsu H.C., Sung F.C., Su T.C., Chen M.F., and Lee Y.T. Metabolic syndrome as a risk factor for coronary heart disease and stroke: an 11-year prospective cohort in Taiwan community. Atherosclerosis 194 (2007) 214-221
5. He Y., Jiang B., Wang J., Feng K., Chang Q., Fan L., et al. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J. Am. Coll. Cardiol. 47 (2006) 1588-1594
6. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissén M., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
7. Alexander C.M., Landsman P.B., Teutsch S.M., Haffner S.M., and Third National Health and Nutrition Examination Survey (NHANES III). National Cholesterol Education Program (NCEP), NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52 (2003) 1210-1214
8. Choi H.S., Ryu S.H., and Lee K.B. The relationship of microalbuminuria with metabolic syndrome. Nephron Clin. Pract. 104 (2006) c85-c93
9. Wong T.Y., Duncan B.B., Golden S.H., Klein R., Couper D.J., Klein B.E., et al. Associations between the metabolic syndrome and retinal microvascular signs: the atherosclerosis risk in communities study. Invest. Ophthalmol. Vis. Sci. 45 (2004) 2949-2954
10. Zhang R., Liao J., Morse S., Donelon S., and Reisin E. Kidney disease and the metabolic syndrome. Am. J. Med. Sci. 330 (2005) 319-325
11. Isomaa B., Henricsson M., Almgren P., Tuomi T., Taskinen M.R., and Groop L. The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. Diabetologia 44 (2001) 1148-1154
12. Kang E.S., Kim H.J., Ahn C.W., Park C.W., Cha B.S., Lim S.K., et al. Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes. Diab. Res. Clin. Pract. 69 (2005) 151-159
13. Nakamura M., Onoda T., Itai K., Ohsawa M., Satou K., Sakai T., et al. Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. Intern. Med. 43 (2004) 919-925
14. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 27 Suppl. 1 (2004) S5-S10
15. Brisk P.S., and Alerbs J.J. Precipitation methods for quantification of lipoprotein. In: Albers J.J., and Segrest J.P. (Eds). Methods in Enzymology (1986), Academic, London 78-100
16. Lee I.T., Sheu W.H., Lin S.Y., Lee W.J., Song Y.M., and Liu H.C. Simvastatin reduces plasma concentration of high-sensitivity C-reactive protein in type 2 diabetic patients with hyperlipidemia. J. Diabetes Complicat. 16 (2002) 382-385
17. American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care 30 Suppl. 1 (2007) S4-S41
18. Matthews D.R., Hosker J.P., Rudenski A.S., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
19. Tan C.E., Ma S., Wai D., Chew S.K., and Tai E.S. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?. Diabetes Care 27 (2004) 1182-1186
20. Zimmet P., Magliano D., Matsuzawa Y., Alberti G., and Shaw J. The metabolic syndrome: a global public health problem and a new definition. J. Atheroscler. Thromb. 12 (2005) 295-300
21. Genuth S., Alberti K.G., Bennett P., Buse J., Defronzo R., Kahn R., et al. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (2003) 3160-3167
22. Davidson M.B. Metabolic syndrome/insulin resistance syndrome/pre-diabetes: new section in diabetes care. Diabetes Care 26 (2003) 3179
23. Simonson G.D., and Kendall D.M. Diagnosis of insulin resistance and associated syndromes: the spectrum from the metabolic syndrome to type 2 diabetes mellitus. Coronary Artery Dis. 16 (2005) 465-472
24. Mellen P.B., Cefalu W.T., and Herrington D.M. Diabetes, the metabolic syndrome, and angiographic progression of coronary arterial disease in postmenopausal women. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 189-193
25. Tzoulaki I., Murray G.D., Lee A.J., Rumley A., Lowe G.D., and Fowkes F.G. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh artery study. Circulation 112 (2005) 976-983
26. Yu H.I., Sheu W.H., Song Y.M., Liu H.C., Lee W.J., and Chen Y.T. C-reactive protein and risk factors for peripheral vascular disease in subjects with type 2 diabetes mellitus. Diabetic Med. 21 (2004) 336-341
27. Vu J.D., Vu J.B., Pio J.R., Malik S., Franklin S.S., Chen R.S., et al. Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adults with the metabolic syndrome, diabetes mellitus, and pre-existing cardiovascular disease. Am. J. Cardiol. 96 (2005) 655-658
28. Tajiri Y., Mimura K., and Umeda F. High-sensitivity C-reactive protein in Japanese patients with type 2 diabetes. Obes. Res. 13 (2005) 1810-1816
29. Gomes M.B., and Nogueira V.G. Acute-phase proteins and microalbuminuria among patients with type 2 diabetes. Diab. Res. Clin. Pract. 66 (2004) 31-39
30. Pannacciulli N., Cantatore F.P., Minenna A., Bellacicco M., Giorgino R., and De Pergola G. Urinary albumin excretion is independently associated with C-reactive protein levels in overweight and obese nondiabetic premenopausal women. J. Intern. Med. 250 (2001) 502-507
31. Otto C., Engelschalk C., Fraunberger P., Laubach E., and Schwandt P. Lack of an association of urinary albumin excretion with interleukin-6 or C-reactive protein in patients with type 2 diabetes. Acta Diabetol. 38 (2001) 153-155
32. Brantsma A.H., Bakker S.J., Hillege H.L., de Zeeuw D., de Jong P.E., Gansevoort R.T., et al., PREVEND Study Group. Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care 28 (2005) 2525-2530
33. Messerli A.W., Seshadri N., Pearce G.L., Sachar R., Hoogwerf B.J., and Sprecher D.L. Relation of albumin/creatinine ratio to C-reactive protein and to the metabolic syndrome. Am. J. Cardiol. 92 (2003) 610-612
34. Stancoven A., and McGuire D.K. Preventing macrovascular complications in type 2 diabetes mellitus: glucose control and beyond. Am. J. Cardiol. 99 (2007) 5H-11H
35. Nakagami T., Qiao Q., Tuomilehto J., Balkau B., Tajima N., Hu G., et al. Screen-detected diabetes, hypertension and hypercholesterolemia as predictors of cardiovascular mortality in five populations of Asian origin: the DECODA study. Eur. J. Cardiovasc. Prev. Rehabil. 13 (2006) 555-561
36. Marín R., Rodríguez P., Tranche S., Redón J., Morales-Olivas F., Galgo A., et al. Prevalence of abnormal urinary albumin excretion rate in hypertensive patients with impaired fasting glucose and its association with cardiovascular disease. J. Am. Soc. Nephrol. 17 (2006) S178-188
37. Wang X.L., Lu J.M., Pan C.Y., Tian H., and Li C.L. A comparison of urinary albumin excretion rate and microalbuminuria in various glucose tolerance subjects. Diabetic Med. 22 (2005) 332-335
38. Gao W., Dong Y., Nan H., Tuomilehto J., and Qiao Q. The likelihood of diabetes based on the proposed definitions for impaired fasting glucose. Diab. Res. Clin. Pract. 79 (2008) 151-155